SecBot SecBot

COSM

Cosmos Health Inc.
Nasdaq· Wholesale-Drugs, Proprietaries & Druggists' Sundries· Inc. NV· CIK 0001474167 Healthcare & Medical Devices
$0.2324 −0.03 (−10.96%)
Oct 26 4:00 PM ET · prev $0.2610
Market cap
$25.5M
Nano cap
Median target
$4.50
+1836% · range $4.50–4.50
Next earnings
Nov 17
in 22 days
1 year
−74.6%
from $0.9160 · Oct 27
30 days
−37.2%
from $0.3700
52-week range
$0.1720–0.9400
−75% from high · low Jun 26
Avg volume 20D
3.04M
Sep 29 spike 9.32M
Short interest
2.56M
≈2.5% of shares · −15.3%
Days to cover
1.0
at average volume
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
12
analyzed by SecBot
SecBot read MIXED 5 reports · 90 days
Balance 2 bearish · 1 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 2/5 ·Next Earnings date, Nov 17, 2026
Strongest BULLISH Cosmos Health issued a CEO letter and press release reaffirming FY2026 revenue guidance >$90M and projecting…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q2 2026: 4 added (0 new), 2 trimmed or exited.

  • Short sellersCOVERING

    Short interest −15.3% to 2.56M shares. 1.0 days to cover, ≈2.5% of shares.

  • TrendDOWNTREND

    21% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
UBS Group AGDOUBLED594,462$110.0K
VANGUARD FIDUCIARY TRUST CODOUBLED333,842$61.8K
NORTHERN TRUST CORPDOUBLED53,887$10.0K
SIMPLEX TRADING, LLCADD7,138$1.3K
GROUP ONE TRADING LLCTRIM1,700$314.00
CITIGROUP INCNEAR_EXIT43$8.00
GEODE CAPITAL MANAGEMENT, LLCADD318,111$100.9K
HRT FINANCIAL LPDOUBLED67,280$21.0K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

12-month targets · 1 analysts

Price is below the lowest target. Median implies +1836%.Targets as of Oct 26, 2026.

Earnings setup

Estimates
Nov 17
reports in 22 days

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 17, 2026
Earnings date
COSM Q3 2026 Earnings Scheduled — 2026-11-17
Recent
Sep 15, 2026
Short interest
Short Interest: COSM down 26% to 3.0M shares
Settlement 2026-09-15 | Days to cover: 1.12 | ≈3.00% of shares outstanding (est.)
Sep 3, 2026
Earnings
Cosmos Health: A Company Transformed — 2026 Year-to-Date
Cosmos Health releases comprehensive 2026 YTD corporate summary.
Aug 28, 2026
Press release
Cosmos Health Strengthens Balance Sheet and Streamlines Capital Structure; Retires $8M ATW Convertible Note One Year Ahead of Maturity, Eliminating Further Dilution From Conversions
Cosmos Health strengthens balance sheet and streamlines capital structure. Retires $8M ATW convertible note, eliminating further dilution.
Aug 24, 2026
Earnings
Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant Categories
Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant…
Aug 24, 2026
Earnings date
COSM Q2 2026 Earnings Scheduled — 2026-08-24

Short side

FINRA· Sep 30, 2026
2,559,806
shares short
-15.3%
vs prior settlement
1.0
days to cover
≈2.5%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 22, 2026 SEC
Cosmos Health issued a CEO letter and press release reaffirming FY2026 revenue guidance >$90M and projecting Q4 U.S…
8-K — Impact 6/10
Oct 16, 2026 SEC
Andreas Bovopoulos filed an amended Schedule 13G, reporting beneficial ownership of 6,522,905 shares of Cosmos Health…
SC 13G/A — Impact 3/10
Oct 9, 2026 SEC
Cosmos Health reported record preliminary Q3 2026 revenue of ~$17.4M (+2% YoY) and record nine-month revenue of…
8-K — Impact 4/10
Sep 15, 2026 Short interest report
Short Interest: COSM down 26% to 3.0M shares
Settlement 2026-09-15 | Days to cover: 1.12 | ≈3.00% of shares outstanding (est.)
Jul 20, 2026 Press
Cosmos Health expands its Sky Premium Life distribution partnership with Pharma Cell in Albania, with average monthly…
Impact 4/10
Jul 17, 2026 Press
Cosmos Health repurchased an additional 274,000 shares at ~$0.2554/share, bringing total buyback to 5,112,000 shares…
Impact 3/10
Jun 30, 2026 Inst.
UBS Group AG — DOUBLED
594,462 shares ($110.0K)
Jun 30, 2026 Inst.
VANGUARD FIDUCIARY TRUST CO — DOUBLED
333,842 shares ($61.8K)

SecBot reports

12 filings · 21 press releases · 1 bullish · 4 bearish · 2 mixed · 5 neutral
All COSM filing & press-release reports (33)